IMMVF
Price
$0.15
Change
-$0.02 (-11.76%)
Updated
Feb 8 closing price
Capitalization
14.59M
Intraday BUY SELL Signals
LZAGF
Price
$670.67
Change
-$7.78 (-1.15%)
Updated
Feb 3 closing price
Capitalization
46.98B
Intraday BUY SELL Signals
Interact to see
Advertisement

IMMVF vs LZAGF

Header iconIMMVF vs LZAGF Comparison
Open Charts IMMVF vs LZAGFBanner chart's image
Immunovia AB
Price$0.15
Change-$0.02 (-11.76%)
Volume$325
Capitalization14.59M
Lonza Group AG
Price$670.67
Change-$7.78 (-1.15%)
Volume$72
Capitalization46.98B
IMMVF vs LZAGF Comparison Chart in %
IMMVF
Daily Signal:
Gain/Loss:
LZAGF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMMVF vs. LZAGF commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMVF is a Hold and LZAGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IMMVF: $0.02 vs. LZAGF: $670.67)
Brand notoriety: IMMVF and LZAGF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IMMVF: 120% vs. LZAGF: 8%
Market capitalization -- IMMVF: $14.59M vs. LZAGF: $46.98B
IMMVF [@Medical Specialties] is valued at $14.59M. LZAGF’s [@Medical Specialties] market capitalization is $46.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMVF’s FA Score shows that 0 FA rating(s) are green whileLZAGF’s FA Score has 1 green FA rating(s).

  • IMMVF’s FA Score: 0 green, 5 red.
  • LZAGF’s FA Score: 1 green, 4 red.
According to our system of comparison, LZAGF is a better buy in the long-term than IMMVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMVF’s TA Score shows that 2 TA indicator(s) are bullish while LZAGF’s TA Score has 5 bullish TA indicator(s).

  • IMMVF’s TA Score: 2 bullish, 3 bearish.
  • LZAGF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LZAGF is a better buy in the short-term than IMMVF.

Price Growth

IMMVF (@Medical Specialties) experienced а 0.00% price change this week, while LZAGF (@Medical Specialties) price change was -9.78% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.33%. For the same industry, the average monthly price growth was -0.33%, and the average quarterly price growth was +22.90%.

Industries' Descriptions

@Medical Specialties (-4.33% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LZAGF($47B) has a higher market cap than IMMVF($14.6M). IMMVF YTD gains are higher at: 0.000 vs. LZAGF (-1.438). LZAGF has higher annual earnings (EBITDA): 1.05B vs. IMMVF (-57.94M). LZAGF has more cash in the bank: 907M vs. IMMVF (26.6M). IMMVF has less debt than LZAGF: IMMVF (20.4M) vs LZAGF (4.61B). LZAGF has higher revenues than IMMVF: LZAGF (7.09B) vs IMMVF (786K).
IMMVFLZAGFIMMVF / LZAGF
Capitalization14.6M47B0%
EBITDA-57.94M1.05B-6%
Gain YTD0.000-1.438-
P/E RatioN/A40.20-
Revenue786K7.09B0%
Total Cash26.6M907M3%
Total Debt20.4M4.61B0%
FUNDAMENTALS RATINGS
IMMVF vs LZAGF: Fundamental Ratings
IMMVF
LZAGF
OUTLOOK RATING
1..100
150
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
9656
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGF's Valuation (19) in the null industry is somewhat better than the same rating for IMMVF (73). This means that LZAGF’s stock grew somewhat faster than IMMVF’s over the last 12 months.

LZAGF's Profit vs Risk Rating (95) in the null industry is in the same range as IMMVF (100). This means that LZAGF’s stock grew similarly to IMMVF’s over the last 12 months.

LZAGF's SMR Rating (92) in the null industry is in the same range as IMMVF (100). This means that LZAGF’s stock grew similarly to IMMVF’s over the last 12 months.

LZAGF's Price Growth Rating (56) in the null industry is somewhat better than the same rating for IMMVF (96). This means that LZAGF’s stock grew somewhat faster than IMMVF’s over the last 12 months.

LZAGF's P/E Growth Rating (90) in the null industry is in the same range as IMMVF (100). This means that LZAGF’s stock grew similarly to IMMVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMMVFLZAGF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
18%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
25%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
7%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
58%
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
61%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
11%
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
IMMVF
Daily Signal:
Gain/Loss:
LZAGF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESLA1.170.08
+7.34%
Estrella Immunopharma
BYND0.760.02
+3.03%
Beyond Meat
AUR4.120.05
+1.23%
Aurora Innovation
BPYPM15.85-0.01
-0.03%
Brookfield Property Partners LP
ELVN27.60-0.57
-2.02%
Enliven Therapeutics

IMMVF and

Correlation & Price change

A.I.dvisor tells us that IMMVF and IDTA have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMVF and IDTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMVF
1D Price
Change %
IMMVF100%
N/A
IDTA - IMMVF
8%
Poorly correlated
N/A
LZAGF - IMMVF
8%
Poorly correlated
-2.11%
LZAGY - IMMVF
6%
Poorly correlated
-1.47%
IVF - IMMVF
4%
Poorly correlated
-6.45%
IOBCF - IMMVF
0%
Poorly correlated
N/A
More

LZAGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGF has been loosely correlated with LZAGY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGF jumps, then LZAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGF
1D Price
Change %
LZAGF100%
-2.11%
LZAGY - LZAGF
61%
Loosely correlated
-1.47%
SAUHF - LZAGF
30%
Poorly correlated
-4.05%
TCHBF - LZAGF
28%
Poorly correlated
N/A
SAUHY - LZAGF
28%
Poorly correlated
-2.68%
SOAGY - LZAGF
26%
Poorly correlated
+7.02%
More